Failure to Diagnose & Delay in Treatment of Non-Hodgkin Lymphoma (Lymph System Cancer)

Evaluate breaches in the standard of care for Failure to Diagnose & Delay in Treatment of Non-Hodgkin Lymphoma (Lymph System Cancer)

Answer the following questions to find out if the standard of care was followed for your case.

  • With which type of lymph node swelling did the patient present?
    Painful
    Painless
    No swelling
    Answer unknown
    Why is this important?
    A majority of patients with Non-Hodgkin’s Lymphoma (NHL) present with painless lymphadenopathy.
    Click here for additional information at ClinicalKey.com

  • With which of the following symptoms did the patient present? (Choose all that apply) Why is this important?
    Answer this question
    Patients with Non-Hodgkin’s Lymphoma present with systemic complaints, including fever, night sweats, and weight loss in conjunction with enlarged lymph glands.
    Click here for additional information at ClinicalKey.com

  • With which of the following risk factors did the patient present? (Choose all that apply) Why is this important?
    Answer this question
    Risk factors are useful for identifying subjects at increased risk for a disease or for a particular outcome that results from a disease process.
    Click here for additional information at ClinicalKey.com

  • Was a physical examination performed? Why is this important?
    Answer this question
    A carefully focused physical examination serves as the core of the diagnostic process. The information obtained guides the further direction of the patient's evaluation and enables the clinician to make the most judicious use of additional tests.
    Click here for additional information at ClinicalKey.com

  • Which of the following laboratory investigations were performed? (Choose all that apply) Why is this important?
    Answer this question
    Blood investigation results may depict a bone marrow picture that may identify organ involvement and may predict prognosis.
    Click here for additional information at ClinicalKey.com

  • Which of the following imaging tests were performed? (Choose all that apply) Why is this important?
    Answer this question
    Imaging tests aid in tumor staging enabling the clinicians to determine whether the tumor has spread, and the extent of the spread.
    (2003) 36 EOTCNA 4 625-646

  • Was a biopsy of the enlarged lymph node performed? Why is this important?
    Answer this question
    Lymph node biopsy is performed to confirm the diagnosis and identify the subtype of lymphoma.
    Click here for additional information at ClinicalKey.com

  • Was the patient diagnosed with Non-Hodgkin’s Lymphoma (NHL)? Why is this important?
    Answer this question
    Accurate diagnosis and staging of Non-Hodgkin’s Lymphomas is crucial to define the nature of the tumor (subtype), extent of disease, and prognostic characteristics.
    Click here for additional information at ClinicalKey.com

  • Were follow-up evaluations advised? Why is this important?
    Answer this question
    Routine follow-up evaluations are necessary to offset any complications that may arise.
    Click here for additional information at ClinicalKey.com

  • Was the patient referred to a hematologist/oncologist? Why is this important?
    Answer this question
    Once priorities and goals have been agreed on, referral to the appropriate professionals should be made in a timely manner. The skills of members from all professional disciplines should be utilized to enable all patients to achieve their maximum potential.
    Click here for additional information at ClinicalKey.com

  • Was a histological, immunophenotypic and cytogenetic analysis performed? Why is this important?
    Answer this question
    The diagnosis of lymphoma is based upon the evaluation of histologic, hematopathologic, immunophenotypic and genetic studies interpreted in the context of the clinical picture.
    Click here for additional information at ClinicalKey.com

  • Which of the following tests were performed to evaluate the extent of disease? (Choose all that apply) Why is this important?
    Answer this question
    All patients with Non-Hodgkins Lymphoma (NHL) need to undergo a Bone Marrow (BM) aspiration and biopsy prior to the initiation of treatment as part of their staging evaluation.
    Click here for additional information at ClinicalKey.com

  • Was the patient’s risk of developing tumor lysis syndrome assessed before initiating treatment? Why is this important?
    Answer this question
    TumorLysis Syndrome (TLS) is an oncologic emergency that is caused by massive tumor cell lysis with the release of large amounts of potassium, phosphate, and nucleic acids into the systemic circulation causing renal failure.
    (1997) 44 EPDCNA 4 809-830

  • Was fertility preservation discussed with the patient before initiating treatment? Why is this important?
    Answer this question
    An overall discussion of fertility issues needs to occur, especially for patients within childbearing age, prior to the initiation of treatment. The discussion should include the possibility of sperm or fertilized ovum banking.
    (2003) 13 EPAECH 3 207-212

  • Was an informed consent obtained and documented? Why is this important?
    Answer this question
    The laws of most states require that an informed consent be obtained before providing treatment.
    (2011) 23 EOMSCA 3 475-484

  • Was pre-treatment testing performed? Why is this important?
    Answer this question
    General assessment needs to include a physical examination and a complete medical history with appropriate hematologic and radiologic investigations.
    Click here for additional information at ClinicalKey.com

  • What type of Non-Hodgkin’s lymphoma did the patient develop? Why is this important?
    Answer this question
    Non-Hodgkin Lymphoma (NHL) refers to a group of malignant diseases that arise from the lymphoid system. Non Hodgkin’s Lymphomas may be of either B-cell or T-cell origin. B-cell lymphomas are more common and T cell lymphomas are associated with poorer outcomes. Clinically, Non Hodgkin’s Lymphomas can be divided into three categories: indolent, aggressive, and highly aggressive.
    Click here for additional information at ClinicalKey.com

  • With which stage of lymphoma was the patient diagnosed? (Choose all that apply) Why is this important?
    Answer this question
    The Ann Arbor staging system is used for the staging of Non Hodgkin’s Lymphomas.
    Click here for additional information at ClinicalKey.com

  • Which of the following treatment modalities were initiated? (Choose all that apply) Why is this important?
    Answer this question
    Not all patients with indolent lymphoma will require treatment. Treatment of indolent non Hodgkin’s lymphoma depends upon the stage of disease at presentation as evaluated by the Ann arbor staging system.
    Click here for additional information at ClinicalKey.com